Paresis acquired in the intensive care unit: a prospective multicenter study.

CONTEXT Although electrophysiologic and histologic neuromuscular abnormalities are common in intensive care unit (ICU) patients, the clinical incidence of ICU-acquired neuromuscular disorders in patients recovering from severe illness remains unknown. OBJECTIVES To assess the clinical incidence, risk factors, and outcomes of ICU-acquired paresis (ICUAP) during recovery from critical illness in the ICU and to determine the electrophysiologic and histologic patterns in patients with ICUAP. DESIGN Prospective cohort study conducted from March 1999 to June 2000. SETTING Three medical and 2 surgical ICUs in 4 hospitals in France. PARTICIPANTS All consecutive ICU patients without preexisting neuromuscular disease who underwent mechanical ventilation for 7 or more days were screened daily for awakening. The first day a patient was considered awake was day 1. Patients with severe muscle weakness on day 7 were considered to have ICUAP. MAIN OUTCOME MEASURES Incidence and duration of ICUAP, risk factors for ICUAP, and comparative duration of mechanical ventilation between ICUAP and control patients. RESULTS Among the 95 patients who achieved satisfactory awakening, the incidence of ICUAP was 25.3% (95% confidence interval [CI], 16.9%-35.2%). All ICUAP patients had a sensorimotor axonopathy, and all patients who underwent a muscle biopsy had specific muscle involvement not related to nerve involvement. The median duration of ICUAP after day 1 was 21 days. Mean (SD) duration of mechanical ventilation after day 1 was significantly longer in patients with ICUAP compared with those without (18.2 [36.3] vs 7.6 [19.2] days; P =.03). Independent predictors of ICUAP were female sex (odds ratio [OR], 4.66; 95% CI, 1.19-18.30), the number of days with dysfunction of 2 or more organs (OR, 1.28; 95% CI, 1.11-1.49), duration of mechanical ventilation (OR, 1.10; 95% CI, 1.00-1.22), and administration of corticosteroids (OR, 14.90; 95% CI, 3.20-69.80) before day 1. CONCLUSIONS Identified using simple bedside clinical criteria, ICUAP was frequent during recovery from critical illness and was associated with a prolonged duration of mechanical ventilation. Our findings suggest an important role of corticosteroids in the development of ICUAP.

[1]  P. Schmitz,et al.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome , 1991, Muscle & nerve.

[2]  D. DuBois,et al.  Disuse atrophy of skeletal muscle is associated with an increase in number of glucocorticoid receptors. , 1980, Endocrinology.

[3]  L. Visser,et al.  Risk factors for the development of polyneuropathy and myopathy in critically ill patients , 2001, Critical care medicine.

[4]  M. Weinmann,et al.  Myopathy in severe asthma. , 1992, The American review of respiratory disease.

[5]  W. Sibbald,et al.  Polyneuropathy in critically ill patients. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[6]  A. Beelen,et al.  Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome , 2000, Disability and rehabilitation.

[7]  M. Konagaya,et al.  Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. , 1986, Endocrinology.

[8]  O. Miettinen,et al.  Estimability and estimation in case-referent studies. , 1976, American journal of epidemiology.

[9]  D. DuBois,et al.  A possible role for glucocorticoids in denervation atrophy , 1981, Muscle & nerve.

[10]  R. Griffiths,et al.  Necrotizing myopathy in critically‐ill patients , 1991, The Journal of pathology.

[11]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[12]  D. Cook,et al.  Risk Factors for Polyneuromyopathy of Critical Illness , 1999 .

[13]  W S David,et al.  Muscle weakness in mechanically ventilated patients with severe asthma. , 1996, American journal of respiratory and critical care medicine.

[14]  F. Leijten,et al.  The Role of Polyneuropathy in Motor Convalescence After Prolonged Mechanical Ventilation , 1995 .

[15]  D. Sale,et al.  Gender differences in strength and muscle fiber characteristics , 1993, European Journal of Applied Physiology and Occupational Physiology.

[16]  A. V. Van Cott,et al.  Acute myopathy after liver transplantation , 1998, Neurology.

[17]  W. Sibbald,et al.  Peripheral nerve function in sepsis and multiple organ failure. , 1991, Chest.

[18]  F. Xue,et al.  The Pharmacokinetics of Vecuronium in Male and Female Patients , 1998, Anesthesia and analgesia.

[19]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .

[20]  F. Walker.  Laboratory reference for clinical neurophysiology Editors: Jay A. Liueson and Dong M. Ma, FA Davis Company, Philadelphia, 1992, 513 pp. $65.00 , 1992 .

[21]  P. Bollaert,et al.  Reversal of late septic shock with supraphysiologic doses of hydrocortisone. , 1998, Critical care medicine.

[22]  J. Lefaucheur,et al.  Acquired neuromuscular disorders in critically ill patients: a systematic review , 1998, Intensive Care Medicine.

[23]  S. Nasraway,et al.  Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. , 2002, Critical care medicine.

[24]  G. Meduri,et al.  Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome: a Randomized Controlled Trial , 1999 .

[25]  D. Annane,et al.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. , 2002, JAMA.

[26]  I. MacFarlane,et al.  SEVERE MYOPATHY AFTER STATUS ASTHMATICUS , 1977, The Lancet.

[27]  R. Woledge,et al.  Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. , 1993, Clinical science.

[28]  D. Recupero,et al.  Critical illness myopathy and neuropathy , 1996, The Lancet.

[29]  M. Haller,et al.  Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. , 1999, Critical care medicine.